The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LEKOIL LIMITED: Holings in Company

27 Jul 2017 17:32

LEKOIL LIMITED (LEK) LEKOIL LIMITED: Holings in Company 27-Jul-2017 / 17:31 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

For filings with the FCA include the annex

 

For filings with issuer exclude the annex

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Lekoil Limited

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

YF Finance Limited

 

4. Full name of shareholder(s) (if different from 3.):iv

See above

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

26 July 2017

6. Date on which issuer notified:

27 July 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 12%

           

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

Ordinary Shares

62,174,062

62,174,062

64,662,848

64,662,848

 

12.05%

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

64,662,848

12.05%

                                 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

 

14. Contact name:

Jamii Quoc, General Counsel

15. Contact telephone number:

+852 2239 5300

     

 


Language:English
ISIN:KYG5462G1073
Category Code:MSCH
TIDM:LEK
Sequence No.:4471
 
End of AnnouncementEQS News Service

596553 27-Jul-2017 

UK-Regulatory-announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

Date   Source Headline
10th Sep 20214:13 pmRNSHolding(s) in Company
10th Sep 202112:47 pmRNSDirector Loan - Update
8th Sep 202112:42 pmRNSCorporate update
2nd Sep 202112:17 pmRNSConvertible Facility Agreement
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCorporate & Operational Update
1st Sep 20214:40 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20212:05 pmRNSSecond Price Monitoring Extn
1st Sep 20212:00 pmRNSPrice Monitoring Extension
1st Sep 202111:59 amRNSHolding(s) in Company
31st Aug 20214:40 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 202111:06 amRNSSecond Price Monitoring Extn
10th Aug 202111:00 amRNSPrice Monitoring Extension
5th Jul 20214:40 pmRNSSecond Price Monitoring Extn
5th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20212:06 pmRNSSecond Price Monitoring Extn
5th Jul 20212:00 pmRNSPrice Monitoring Extension
2nd Jul 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20212:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSChange of website address
21st Jun 20213:30 pmRNSResignation of CFO
18th Jun 202112:53 pmRNSDirectorate Change
17th Jun 20217:00 amRNSDelay in publication of Annual Results for 2020
10th Jun 20217:00 amRNSCorporate Update
3rd Jun 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSAward of Options
20th Apr 20217:07 amRNSDirectorate Change
15th Apr 20218:15 amRNSDirectorate Change
26th Mar 20217:00 amRNSTrading and operational update
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20211:45 pmRNSDirector Loan - Update
26th Feb 20217:00 amRNSTR-1: notification of major holdings
24th Feb 20217:00 amRNSRe Cost and Revenue Sharing Agreement for OPL 310
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSJoint Broker Appointment
11th Jan 20217:00 amRNSAppointment of Chairman
8th Jan 202112:28 pmRNSResult of EGM
8th Jan 20217:00 amRNSRE Extraordinary General Meeting
7th Jan 20211:20 pmRNSResponse to Press Speculation
31st Dec 202012:43 pmRNSJoint Broker Resignation
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20206:05 pmRNSAppointment of Nominated Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.